KEYWORDS
Treatment Considerations, Drug Development, Non-Biological Therapies, Anticoagulant Drugs, Clinical Practice (Health Services and Quality), Diseases, Bleeding and Clotting, Thromboembolism, Thrombotic Disorders, Research, Clinical Research, Clinical Trials, Health Outcomes Research, Study Population, Human, Adult, Pediatric